Abbott India · NSE: ABBOTINDIA · BSE: 500488
Q3 FY25 results · Oct–Dec 2024
Abbott India reported revenue from operations of ₹1,614.28 crore (up 12.3% from Q3 FY24) and net profit of ₹360.78 crore (up 16.0% from Q3 FY24) for Q3 FY25 (Oct–Dec 2024), on a standalone basis.
| Item | Q3 FY25 | Q3 FY24 | YoY | Q2 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,614.28 | 1,437.14 | +12.3% | 1,632.67 | −1.1% |
| Other income | 71.75 | 55.61 | +29.0% | 60.48 | +18.6% |
| Total income | 1,686.03 | 1,492.75 | +12.9% | 1,693.15 | −0.4% |
| Profit before tax | 487.59 | 422.16 | +15.5% | 479.43 | +1.7% |
| Net profit for the period | 360.78 | 310.98 | +16.0% | 358.61 | +0.6% |
| EPS, basic (₹) | 169.78 | 146.34 | +16.0% | 168.76 | +0.6% |
| Net margin (%) | 22.3 | 21.6 | 22.0 |
Standalone
- Filed with BSE
- 05 Feb 2025, 14:42 IST
- Board meeting
- 05 Feb 2025
- Period
- 01 Oct 2024 to 31 Dec 2024
- Review status
- Audited
- Source
- XBRL filing on BSE